top TOP
February 1, 2024

Yaara Oren, PhD

Tel Aviv University

The Barbara and Fred Kort Foundation Research Career Development Award

Despite a favorable initial response to therapy, 30% of cancer patients will experience relapse and die within five years of diagnosis. It is not clear why some cancer cells that initially respond to treatment can ultimately dodge it and refuel tumor growth. Dr. Oren’s team is developing a new tool to track and study cells that escape post-treatment senescence, in which cells stop dividing and proliferating, thus preventing tumor growth. The study should help spur the development of new therapies that delay or even prevent recurrent disease.  

View Grant Recipient Profile

Help End the Suffering Caused By Cancer

The answer to cancer is research. Support groundbreaking cancer research in Israel today: